By - Reuters
March 24 (Reuters) - GSK plc:
* GSK PLC - STATEMENT: ZANTAC (RANITIDINE) LITIGATION
* GSK - GSK RESPECTFULLY DISAGREES WITH SARGON RULING BY CALIFORNIA STATE COURT IN RESPECT OF GOETZ CASE
* GSK, ON ZANTAC (RANITIDINE) LITIGATION, SAYS WILL PRESS ADDITIONAL DEFENCES
* GSK - THURSDAY'S DECISION RELATES ONLY TO QUESTION OF WHETHER PLAINTIFF'S EXPERTS CAN TESTIFY AT TRIAL IN GOETZ CASE Source text for Eikon: Further company coverage: